A carregar...
Improvement of glycemic control by treatment for insomnia with suvorexant in type 2 diabetes mellitus
INTRODUCTION: Acute and chronic insomnia can exacerbate type 2 diabetes mellitus (T2DM). We investigated suvorexant (an anti-insomnia drug that targets the orexin system) effects on sleep architecture and glucose metabolism in T2DM patients with insomnia. MATERIALS AND METHODS: This 7 day open-label...
Na minha lista:
| Publicado no: | J Clin Transl Endocrinol |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6306692/ https://ncbi.nlm.nih.gov/pubmed/30619717 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcte.2018.12.006 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|